The Dow Jones Industrial Average advanced overnight, boosted by shares of Merck and Intel, though disappointing manufacturing data kept a lid on gains.
Shares of Merck, last up 4.1 per cent, bolstered the Dow as one of the company's new cancer drugs showed promising results in an early study. Shares of Intel also advanced, last up 3.1 per cent, after a FBR Capital Markets upgrade.
However, the latest US manufacturing data showed a surprise contraction. The Institute for Supply Management's factory index dropped to 49 in May, the lowest reading in four years, from 50.7 in April.
"There's nothing here that indicates a recession, just that things are going to be perhaps a little bit softer," Scott Brown, chief economist at Raymond James in St Petersburg, Florida, told Reuters.
"The key question, particularly for the Fed, is what does the data imply for the future?" Brown said. "Are things going to be strong enough that they're going to pick up in the second half?"